-

Taro to Announce Full Year Results on May 19, 2021

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2021, on Wednesday, May 19, 2021.

The release will be accessible on Taro’s website at www.taro.com.

About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Contacts

Daphne Huang
VP, CFO
(914) 345-9001
Daphne.Huang@taro.com

William J. Coote
AVP, Treasurer and Investor Relations
(914) 345-9001
William.Coote@taro.com

Industry:

Taro Pharmaceutical Industries Ltd.

NYSE:TARO
Release Summary
Taro to Announce Full Year Results on May 19, 2021
Release Versions
English

Contacts

Daphne Huang
VP, CFO
(914) 345-9001
Daphne.Huang@taro.com

William J. Coote
AVP, Treasurer and Investor Relations
(914) 345-9001
William.Coote@taro.com

More News From Taro Pharmaceutical Industries Ltd.

Taro Provides Results for Year Ended March 31, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024...

Taro to Release Full Year Results on May 20, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO TO RELEASE FULL YEAR RESULTS ON MAY 20, 2024...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger

NEW YORK--(BUSINESS WIRE)--Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger...
Back to Newsroom